Advancing the Future of Cancer Therapies with Nanotechnology
About Us
OncoNano is a clinical-stage oncology company working to transform cancer therapeutics with its proprietary nanotechnology platform.
Technology
OncoNano's ON-BOARD™ polymeric micelle platform is designed to leverage universal tumor targets to precisely deliver anti-tumor payloads to the tumor microenvironment.
Pipeline
OncoNano is developing a differentiated pipeline of novel therapies to tackle cancer's greatest challenges.
News
May 2024
March 2024
April 2024
Contact Us
Headquarters
OncoNano Medicine, Inc.
3060 Pegasus Park
Dallas, Texas 75247
info@onconanomed.com